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ABSTRACT
Background and aims Crohn’s disease (CD) ileal lesions
are colonised by pathogenic adherent-invasive
Escherichia coli (AIEC) producing outer membrane
vesicles (OMVs) that contribute to the bacterial invasion
process. In addition, increased expression of
endoplasmic reticulum (ER)-localised stress response
proteins, due to ER stress, is observed in patients with
CD. The expression of the ER-localised stress response
protein Gp96 in patients with CD and its biological role
with regards to the ability of AIEC to invade intestinal
epithelial cells were analysed.
Methods and results Immunohistochemistry on tissue
arrays showed that, together with CEACAM6
(carcinoembryonic antigen-related cell adhesion
molecule 6) or the ER stress protein Grp78, Gp96 is also
strongly expressed at the apical plasma membrane of
the ileal epithelial cells of 50% of patients with CD.
Invasion experiments in the presence of antibodies raised
against Gp96, or after transfection of Intestine-407 cells
with gp96 small interfering RNA (siRNA), indicated that
Gp96 is essential to promote AIEC LF82 invasion, allowing,
via the recognition of the outer membrane protein OmpA,
OMVs to fuse with intestinal epithelial cells.
Conclusions Gp96 is overexpressed on the apical surface
of ileal epithelial cells in patients with CD and acts as
a host cell receptor for OMVs, promoting AIEC invasion.
From the results shown here, it is speculated that AIEC
could take advantage of the abnormal expression of Gp96
in patients with CD to invade the ileal mucosa.
INTRODUCTION
Inﬂammatory bowel disease (IBD) mainly
comprises two disorders, ulcerative colitis (UC) and
Crohn’s disease (CD), with a combined prevalence
of w150e200 cases per 100 000 in Western coun-
tries. The abnormal inﬂammatory response
observed in IBD requires interplay between host
genetic factors and the intestinal microbiota.1 2
Several lines of evidence support the notion that
IBD results from an excessive immune response to
gut commensal organisms.1 3 However, the disease
could result from a problem in the composition of
the microﬂora leading to generalised or localised
dysbiosis. Increased numbers of mucosa-associated
Escherichia coli are observed in patients with CD.4e9
These mucosa-associated E coli, called AIEC for
adherent-invasive E coli, are able to adhere to and
invade intestinal epithelial cells (IECs),6 10 and to
colonise the ileal mucosa of patients with CD.11
AIEC are able to promote their own colonisation in
genetically predisposed patients who develop ileal
CD by inducing increased expression of CEACAM6
(carcinoembryonic antigen-related cell adhesion
molecule 6), which acts as a receptor for these
bacteria.12
Among the virulence factors harboured by AIEC
strains, outer membrane vesicles (OMVs), by deliv-
ering bacterial effectors to host cells, play a role in
the invasive ability of AIEC reference strain LF82.13
Through their interaction with eukaryotic cells,
Significance of this study
What is already known about this subject?
< Colonisation of Crohn’s disease (CD) ileal lesions
by pathogenic adherent-invasive Escherichia coli
(AIEC).
< Contribution of outer membrane vesicles
(OMVs) to the invasion process of the reference
AIEC strain LF82 with intestinal epithelial cells.
< Presence on the OMVs surface membrane of
OmpA: a multifaceted protein with many diverse
roles in adhesion, invasion and persistence of
intracellular bacteria.
< Expression of the endoplasmic reticulum (ER)-
localised stress response chaperone Gp96 by
intestinal epithelial cells.
< Key role of ER stress in patients with CD.
What are the new findings?
< Overexpression of Gp96 on the apical surface of
ileal epithelial cells in patients with CD.
< Role of OmpA in the AIEC invasion process.
< Role of Gp96 to promote invasion of the AIEC
reference strain LF82 allowing, via the recogni-
tion of the outer membrane protein OmpA,
OMVs to fuse with intestinal epithelial cells.
How might it impact on clinical practice in the
foreseeable future?
< From the results shown here, we speculate that
AIEC could take advantage of the abnormal
expression of Gp96 in patients with CD to
invade the ileal mucosa. Strategies to inhibit the
OmpAeGp96 interaction would be helpful to
develop new treatment options for preventing
inflammation resulting from gut mucosa invasion
by AIEC but also by virulent bacteria using Gp96
as a host cell receptor.
< Additional material are
published online only. To view
these files please visit the
journal online (http://gut.bmj.
com).
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OMVs, which are 50e200 nm proteoliposomes, can deliver
vesicle components and virulence factors to or into host cells.14 15
One of the major proteins on the surface membrane of OMVs is
the OmpA protein, a multifaceted protein with many diverse
roles in adhesion, invasion and persistence of intracellular
bacteria.16e18 Among its biological roles, it is implicated in the
ability of meningitis-associated E coli to invade brain microvas-
cular endothelial cells (BMECs) via interaction with the endo-
thelial cell glycoprotein Ecgp96.19 20 A homologue of Ecgp96
glycoprotein is expressed by IECs: the endoplasmic reticulum
(ER)-localised stress response chaperone Gp96.21 Interestingly, ER
stress was recently reported to have a key role in both patients
with UC and those with CD after the discovery of single nucle-
otide polymorphisms within the XBP1 gene encoding the tran-
scription factor XBP1, a key component of the ER stress
response.22 23 Therefore, in the present study, we analysed Gp96
expression in patients withCD and its biological role with regards
to AIEC colonisation and invasion of CD ileal mucosa.
MATERIALS AND METHODS
Patients and biopsy specimens
All patients included in this study were hospitalised in the
Department of Gastroenterology (Archet II Hospital, University
of Nice Sophia Antipolis, France) and provided a signed agree-
ment for this study, and the protocol was approved by the local
ethics committee of the University of Nice Sophia Antipolis.
Intestinal biopsies were obtained from macroscopically
inﬂamed mucosa of the terminal ileum and of the colon in 65
patients with CD (active CD) and from macroscopically non-
inﬂamed mucosa of the terminal ileum and of the colon in 55
patients with CD (quiescent phase of the disease). There were
67 men and 53 women, with a mean age of 40 years (range
19e60) and mean disease duration of 10 years (range 2e23).
Patients were all French Caucasians. In addition, biopsies were
taken from the ileum and colon of 40 control patients consisting
of individuals who had no signiﬁcant pathological ﬁndings
following endoscopic examination for changes in stool habits,
abdominal pain, upper gastrointestinal bleeding or cancer
surveillance.
Tissue microarray (TMA) construction and
immunohistochemistry
Representative intestinal biopsies obtained for each individual
in building TMAs were selected from H&E-stained sections.
Brieﬂy, one tissue core (600 mm in diameter) was obtained from
each specimen from the upper part of the mucosa; pits and
glands were always cut longitudinally. The tissue cores were
arrayed into a new parafﬁn block using a ﬁne steel needle. The
two ﬁnal TMAs consisted of one 480e600 mm diameter tissue
core and one 480, 600 mm diameter tissue core, for ileum mucosa
or colonic mucosa, respectively, from patients and controls.
Immunohistochemical methods were performed on serial 4 mm
deparafﬁnised TMA sections processed as described.24 Mono-
clonal rat anti-Gp96 (SPA-850, Stressgen Biotechnologies, San
Diego, California, USA), monoclonal anti-CEACAM6 clone 9A6
(Genovac, Freiburg, Germany) and polyclonal goat anti-Grp78
(N-20, Santa-Cruz Biotechnology, Santa Cruz, California, USA)
were used. For measurement of histological disease activity, the
scoring system for histological abnormalities in CD mucosal
biopsy specimens was used.25 After immunostaining, slides
were analysed with an image analysis workstation (Spot
Browser version 7; Alphelys, Plaisie, France), as described
previously.24
Bacterial strains, plasmids and culture conditions
Bacterial strains, plasmids and oligonucleotides used in this
study are listed in tables 1 and 2. For bacterial growth, isogenic
mutant constructions26 27 and transcomplementation experi-
ments, see supplemental methods online.
OMV preparation
OMVs were isolated as described previously.13 The culture
supernatants were ﬁltered and OMVs were collected by ultra-
centrifugation at 150 000 g for 3 h at 48C. OMV pellets were
resuspended in 10 mM TriseHCl pH 8.0, 150 mM NaCl.
Cell culture, transfection and invasion assays
Intestine-407 and Caco-2 cells were obtained from the American
Type Culture Collection (ATCC). The 19-mer oligonucleotides
(59-UCAGUUGGAUGGAUUAAAU-39 speciﬁc to the gp96
mRNA and 59-UUCUCCGAACGUGUCACGU-39 as a control)
were selected for synthesis of small interfering RNA (siRNA),
cloned into pSUPER vector (Oligoengine, Seattle, Washington,
USA) and transfected with Lipofectamine 2000 (Invitrogen,
Carlsbad, California, USA) according to the manufacturer ’s
instructions. Bacterial invasion was quantiﬁed as described
previously.10 Monolayers were infected for 3 h at a multiplicity
of infection (MOI) of 10 bacteria per cell and the number of
intracellular bacteria was determined as described.28 Inhibition
invasion assays were performed after a 30 min pretreatment of
cells at 378C using anti-Gp96 (H-212, Santa Cruz Biotech) or
rabbit immunoglobulin G (IgG; isotype control, C-20, Santa
Cruz Biotech). Pretreatment of IECs with OMVs was performed
as previously described.13 For pretreatment of IEC with anti-
bodies and OMVs, monolayers were ﬁrst incubated for 30 min
with anti-Gp96 (diluted 1:500), and next for 1 h with OMVs,
then washed and infected.
mRNA quantification, protein preparation and analysis, ligand
overlay assay and pull-down assay
See supplemental methods.
Yeast cell aggregation assays
Yeast cell aggregation assays were performed as described.13
Confocal microscopy
After 10 min incubation in the presence of OMVs, cells
were washed, ﬁxed and immunostained with rat anti-Gp96
monoclonal antibody (SPA-850) and rabbit antiserum against
E coli lipopolysaccharide O83 (generously provided by Lothar
Beutin). Secondary antibodies used were ﬂuorescein isothiocya-
nate (FITC)-conjugated donkey antirabbit IgG (Sigma-Aldrich,
St Louis, Missouri, USA) and Cy3-conjugated AfﬁniPure goat
antirat IgG (Jackson Immuno Research Laboratories, Westgrove,
Pennsylvania, USA). Cells were observed with a Zeiss LSM 510
Meta confocal microscope.
Statistical analysis
For analysis of the signiﬁcance of difference in Gp96 immunos-
taining, assays were compared using the Student t test. Values
are expressed as the mean6SEM of ‘n’ number of experiments.
The association of Gp96 expression with categorical pathological
features was made using c2 analysis. Calculations and analyses
were performed with SPSS 11.5 for Windows, and, where
appropriate, were two-tailed. Student t test was used for anal-
ysis of the statistical signiﬁcance between invasion levels.
p Values $0.05 were considered statistically signiﬁcant.
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RESULTS
Gp96 protein expression is strongly increased in the ileal
intestinal epithelium of patients with CD
Intestinal biopsies were processed for Gp96 immunostaining on
ileal and colonic mucosa of 65 patients with CD with macro-
scopically inﬂamed mucosa, of 55 patients with CD with non-
inﬂamed mucosa and of 40 controls using anti-Gp96 monoclonal
antibody (ﬁgure 1A). Immunohistochemistry showed a very
strong staining of Gp96 in the ileal epithelium of patients in the
acute phase of CD, in contrast to control ileal biopsies that
showed very weak or no Gp96 expression. The Gp96 expression
level in the ileum from patients in the quiescent phase of CD
was still increased compared with that in the ileum from
controls. In patients with CD, Gp96 was mainly observed at the
apical plasma membrane of the epithelium. Conversely, a weak
staining or an absence of staining was noted in colon biopsies
taken both in controls and in patients with CD. In patients with
CD in the active phase, Gp96 immunostaining was observed in
33/65 (50%) individuals, whereas in patients in the quiescent
phase Gp96 immunostaining was observed in 19/55 (34%)
individuals. Concerning positive cell densities in ileal biopsies,
quantiﬁcation of Gp96 immunostaining indicated that the
numbers of Gp96-positive cells in patients in the acute or
quiescent phase of CD were similar and signiﬁcantly higher than
those observed in controls (ﬁgure 1B). Conversely, very few
positive cells were observed in colon biopsies from controls and
subjects with CD (ﬁgure 1B). As CEACAM6 is abnormally
expressed in ileal mucosa of patients with CD12 and as the
expression of Grp78, another ER-localised stress response chap-
erone, is also increased in inﬂamed ileal CD mucosa and in
inﬂamed colonic UC and CD mucosa,23 29 we analysed the
expression of Gp96, CEACAM6 and Grp78 in CD ileal and
colonic specimens. As shown in ﬁgure 1C, very strong staining
of Gp96 was observed together with that of Grp78 and of
CEACAM6 at the apical plasma membrane of the ileal epithe-
lium of patients with CD. Western blot analysis of total protein
extracts from CD ileal specimens taken in involved areas and of
controls showed a strong expression of Gp96 in ﬁve out of six
CD ileal mucosa specimens and only one out of six ileal mucosa
specimens of controls (ﬁgure 1D).
Stimulation by interferon g (IFNg) and tumour necrosis factor
a (TNFa) or bacterial infection do not modify Gp96 expression in
IECs
To investigate whether abnormal Gp96 expression in patients
with CD resulted from stimulation by proinﬂammatory cyto-
kines or E coli infection of IECs, we analysed Gp96 expression in
cultured IECs after stimulation with IFNg or TNFa or after
infection with AIEC. No modiﬁcation in gp96 mRNA levels was
observed in Caco-2 cells after TNFa or IFNg stimulation for 24
or 48 h compared with non-treated cells (ﬁgure 2A). Western
blot analysis indicated that, unlike CEACAM6 increased
expression under proinﬂammatory cytokine stimulation, similar
Gp96 expression was observed in proinﬂammatory cytokine-
stimulated or unstimulated Caco-2 cells (ﬁgure 2B). In addition,
the Gp96 protein level was also not modiﬁed in Caco-2 cells after
3 h of infection by AIEC strain LF82 at an MOI of 10 or 100
(ﬁgure 2C). Similar results were observed with Intestine-407
cells (data not shown).
Gp96 expression supports LF82 invasion
The role of Gp96 in AIEC invasion of IECs was investigated
using invasion inhibition assays in the presence of anti-Gp96
polyclonal antibodies and by invasion assays using IECs with
decreased levels of gp96 by RNA silencing. When the IECs were
pretreated with anti-Gp96 antibodies (dilution 1:200), the
invasion level of LF82 bacteria was 54.563.3% of that of strain
LF82 on untreated cells (ﬁgure 3A). In contrast, pretreatment
with anti-IgG isotype control had no effect on LF82 invasion.
Interestingly, reduced Gp96 expression by transfecting IECs
with gp96 siRNA (ﬁgure 3B) induced decreased LF82 invasion
levels (ﬁgure 3C). Indeed, the invasion levels of LF82 bacteria on
Table 1 Bacterial strains and plasmids used in this study
Strain or
plasmid Relevant characteristics
Source or
reference
Strains
LF82 E coli isolated from an ileal biopsy of a
patient with CD
6
LF82-DompA LF82 isogenic mutant with the ompA
gene deleted
This study
K-12 MG1655 Non-pathogenic E coli strain Laboratory stock
Plasmids
pKOBEG pBAD cloning vector harbouring the l phage
redgba operon, chloramphenicolr
27
pBAD33 E coli cloning vector, chloramphenicolr 47
pPBI13 pBAD33 harbouring the 1.1 kb HindIIIeSalI
fragment with the entire ompA gene
of strain LF82
This study
pPBI14 pBAD33 harbouring the 1.1 kb HindIIIeSalI
fragment with the entire ompA gene of
strain MG1655
This study
pSUPER.neo Vector system for expression of small
interfering RNA
Oligoengine
gp96 siRNA pSUPER.neo harbouring the oligonucleotide
specific to the gp96 mRNA
This study
Control siRNA pSUPER.neo harbouring the oligonucleotide
control
This study
Table 2 Oligonucleotides used for PCR experiments
Primer
Oligonucleotide sequence
(59e39)
PCR
product
size (bp) Use
A2GBL-3 AAAGCCACGTTGTGTCTCAA 957 Kanamycin resistance
cassette amplificationB2GBLnp5 TTAGAAAAACTCATCGAGCA
MIompA(R) AAAGGCAAAAAAAACCCCG
CAGCGGGGTTTTTCTACCAG
ACGAGAACTTAGAAAAACT
CATCGAGCA
1097 DompA isogenic
mutant construction
MIompA(F) CTCGTTGGAGATATTCATGG
CGTATTTTGGATGATAACGA
GGCGCAAAAAAAAGCCACG
TTGTGTCTCAA
OmpA1 GGAGCCGGAGCAACTACTGG 205 Isogenic mutant
verificationOmpA2 ACGACACCGGCGTTTCTCCG
OmpA3 GCAGGCATTGCTGGGTAAGG 1232 Isogenic mutant
verification
and sequencing
OmpA4 AATATTGAGCAGATCCCCCGG
OmpASalI ACGCGTCGACCGTTGGAGAT
ATTCATGGCG
1098 Cloning of ompA gene
OmpAHindIII CCCAAGCTTGGGAGACGAG
AACTTAAGCCTGC
gp96-upstream GGGTGTGGTGGACTCAGATG 669 gp96 quantification by
qRTePCR48gp96-downstream GTTGCCAGACCATCCGTACT
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Intestine-407 cells transfected with gp96 siRNAwere 30.965.0%
of that of strain LF82 on untreated cells. In contrast, trans-
fection of cells with control siRNA that did not reduce the Gp96
protein level did not affect the ability of AIEC strain LF82 to
invade IECs. Taken together, these results strongly suggest that
Gp96 plays a major role in AIEC invasion.
OmpA binds Gp96 and is involved in AIEC strain LF82 invasion
ability
To investigate whether OmpA expressed by LF82 bacteria binds
Gp96 receptor expressed by Caco-2 IECs, we used pull-down and
a ligand overlay approach. As shown in ﬁgure 4A, OmpA from
AIEC strain LF82 was detected after pull-down using rat anti-
Gp96 monoclonal antibody. A similar result was observed with
OmpA from E coli K-12 strain MG1655. The control reaction
without anti-Gp96 antibody captured non-speciﬁc proteins but
not OmpA. However, using the ligand overlay approach, we
observed one band of w100 kDa, the predicted size of Gp96,
after incubation with OMP extracted from wild-type strain
LF82, but not from the LF82-DompA mutant or from E coli K-12
(ﬁgure 4B). Analysis of OmpA sequences revealed that the LF82
strain OmpA differed from that of the non-pathogenic E coli
K-12 strain MG1655 by ﬁve amino acids: two amino acids
located in one of the periplasmic domains, one in the trans-
membrane domain and two in the third extracellular loop of the
OmpA protein (Supplemental ﬁgure S1).
Since OmpA plays a major role in the ability of meningitis-
associated E coli K1 to invade human BMECs via its binding to
the Gp96 receptor,19 20 we investigated the role of OmpA in the
ability of AIEC strain LF82 to invade IECs. The LF82 isogenic
mutant with the ompA gene deleted presented no defect in type
1 pili expression. Electronic microscopic examination of nega-
tively stained bacteria indicated that the bacteria expressed type
1 pili (data not shown), and similar titres (1/8) of yeast cell
Figure 2 Gp96 expression in Caco-2
cells. (A) Fold variation of gp96 mRNA
levels in Caco-2 cells after 24 or 48 h of
stimulation with tumour necrosis factor
a (TNFa) or interferon g (IFNg) relative
to that in non-treated cells (NT) using
RTePCR. gapdh (glyceraldehyde
phosphate dehydrogenase) mRNA levels
were measured as controls. Data are the
mean6SEM of three separate
experiments. (B and C). Western blot
analysis showing expression levels of Gp96 and carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) by Caco-2 cells after 24 or
48 h of stimulation with 50 ng/ml TNFa or IFNg (B) or after a 3 h infection period with adherent-invasive Escherichia coli (AIEC) strain LF82 (C) at
a multiplicity of infection of 10 or 100. As loading control, labelling was performed using anti-b-actin polyclonal antibodies.
Figure 1 Gp96 expression in the
intestinal biopsies of patients with
Crohn’s disease (CD) and controls. (A)
Gp96 immunohistochemical staining of
tissues microarrays (TMAs) from ileum
and colon biopsies of controls (a, b),
patients in the acute inflamed phase
(c, d) or patients in the quiescent phase
(e, f) of CD. Each spot shows
representative tissue immunostaining
for Gp96 (aef, immunoperoxidase 340;
c and e, inset, immunoperoxidase
3200). (B) Quantification of Gp96
immunostaining using the Spot Browser
software, in TMAs from colon and ileum
biopsies of controls, and patients in the
acute or quiescent phase of CD,
**p<0.01. (C) Carcinoembryonic
antigen-related cell adhesion molecule 6
(CEACAM6), Grp78 and Gp96
immunostaining of TMAs from ileum
biopsies of patients with CD,
magnification 3400. (D) Western blot
analysis of whole protein extracts from
ileal biopsies taken in involved areas of
six patients with CD and from six ileal
biopsies from controls using anti-Gp96
and anti-b-actin antibodies.
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aggregation were obtained compared with the wild-type strain
LF82 (ﬁgure 4C), indicating that the LF82-DompA isogenic
mutant synthesised levels of functional type 1 pili similar to the
wild-type strain LF82 (ﬁgure 4C). A quantitative invasion assay
showed that the LF82-DompA mutant has a reduced ability to
invade Intestine-407 epithelial cells, with a 56.362.6% residual
invasion level compared with the wild-type strain LF82, taken as
100% (ﬁgure 4C). Transcomplementation with the cloned ompA
gene of AIEC strain LF82 fully restored the invasion of the
mutant. Transformation of the LF82-DompA mutant with the
cloned ompA gene of E coli K-12 strain MG1655 did not restore
invasion to a level similar to that of the wild-type LF82
(ﬁgure 4C). This was not due to defects in OmpA expression
since the amounts of OmpA produced were similar in LF82-
DompA bacteria transcomplemented with cloned ompA from
AIEC strain LF82 or cloned ompA from E coli K-12 (ﬁgure 4C).
Thus amino acid substitution in LF82 OmpA favours the inter-
action of OmpA with Gp96 in order to promote IEC invasion.
The ability of LF82 OMVs to promote invasion involves OmpA
and Gp96
The ability of LF82 OMVs to restore the invasion of the LF82-
DompA isogenic mutant was analysed. The invasion level of the
LF82-DompA mutant was increased when the IECs were
pretreated with LF82 OMVs, reaching 85.265.3%, and was not
signiﬁcantly different from that of strain LF82 taken as 100%
(ﬁgure 4D). On the host side, this involved Gp96 as addition of
anti-Gp96 polyclonal antibodies blocked the restoration of the
invasion level of the LF82-DompA mutant with LF82
OMV-treated cells. On the bacterial side, this involved OmpA,
as no increase in the invasion level of the LF82-DompA mutant
was observed with IECs pretreated with LF82-DompA OMVs
(ﬁgure 4D). This was conﬁrmed by confocal analysis of the
interaction of LF82 OMVs with Intestine-407 cells using anti-
O83 to label OMVs. As shown in ﬁgure 4E, a co-localisation of
OMVs with plasma membrane of some Gp96-expressing Intes-
tine-407 cells was observed, as the result of the fusion of LF82
OMVs with the host cell membrane. In addition, confocal
images indicated a recruitment or accumulation of Gp96 at the
cell surface at the sites where the OMVs were observed. No
fusion event of OMVs with the host cell membrane was
observed when experiments were performed with Intestine-407
cells transfected with gp96 siRNA (data not shown) or with
LF82-DompA OMVs (ﬁgure 4E), indicating a role for
OmpAeGp96 interaction in the fusion of LF82 OMVs with the
host cell membrane.
DISCUSSION
We show in the present study that the ER-localised stress
response chaperone Gp96 is overexpressed at the apical plasma
membrane of IECs of patients with CD, and plays a role in the
internalisation of AIEC mainly associated with the ileal mucosa
of patients with CD. Such a result illustrates the hypothesis that
the pathogenesis of CD involves a complex interplay between
host genetic proﬁle and microbes. The heat shock glycoprotein
Gp96 was reported to be highly expressed in rheumatoid
arthritis tissues30 and in advanced tumour stage in oesophageal
adenocarcinomas.31 This is the ﬁrst report showing a connection
between modiﬁed expression of Gp96 in IECs and IBD. In good
accordance with Grp78, another ER-localised stress response
chaperone whose expression is increased in inﬂamed ileal CD
mucosa and in inﬂamed colonic UC and CD mucosa,23 29 the
increased expression of Gp96 in ileal epithelium of patients with
CD could indicate an ER stress. The idea that ER stress is
involved in IBD is quite novel; however, it is now well recog-
nised that unresolved ER stress, as the consequence of genetic
abnormalities of the unfolded protein response or of a variety of
secondary (inﬂammation and environmental) factors, leads to
IEC, goblet cell and Paneth cell dysfunction.22 23 Several single
nucleotide polymorphisms within the XBP1 gene encoding the
transcription factor XBP1, a key component of the ER stress
Figure 3 Gp96 expression supports LF82 invasion. (A) Effect of
pretreatment of Intestine-407 epithelial cells with anti-Gp96 antibodies
on the invasive level of LF82. Intestine-407 cells were pretreated with
rabbit polyclonal antibodies raised against Gp96 (Gp96 Ab) or with rabbit
polyclonal antibodies (isotype control) diluted 1:200 or 1:500 for 30 min
and then infected by LF82 bacteria. Invasion was determined after a 3 h
infection period and after gentamicin treatment for an additional hour.
Results are expressed as intracellular bacteria relative to those obtained
for strain LF82 on non-treated cells (NT), taken as 100%. Each value is
the mean6SEM of at least four separate experiments. *p<0.05
compared with the wild-type strain on untreated cells. (B) Western blot
analysis of whole protein extracts from Intestine-407 cells using anti-
Gp96 and anti-b-actin antibodies. Intestine-407 cells were non-trans-
fected (NT), or transfected with 10 ng of small interfering RNA blocking
Gp96 (gp96 siRNA), or non-specific siRNA as control. (C) Effect of gp96
siRNA on the invasive level of the wild-type strain LF82. Invasive
bacteria were quantified as described in A. **p<0.01 compared with
the wild-type strain on untreated cells.
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response as shown in a knock-out mouse model,23 were observed
both in patients with CD and in those with UC.23 32e35
The increased expression of the ER stress response chaperone
Gp96 in CD could be either a primary cause or a consequence of
intestinal inﬂammation, since it was reported that Gp96 is
transcriptionally upregulated in IFNg-treated human Burkitt’s
lymphoma Daudi cells and HeLa cells.36 Here using cultured
intestinal epithelial Caco-2 or Intestine-407 cells stimulated
with TNFa or IFNg, we did not notice any modiﬁcation of Gp96
expression. This latter observation is in good agreement with
the fact that Gp96 was found to be highly expressed in patients
in both acute and quiescent phases of CD. We also investigated
whether infection with AIEC pathogenic bacteria can interfere
with Gp96 expression, but we did not observe any increase in
response to AIEC infection. The biological function of Gp96 in
the interaction of AIEC with IECs was determined by invasion
experiments in the presence of antibodies raised against Gp96 or
after transfection of Intestine-407 cells with gp96 siRNA. Both
experiments showed a decreased invasion of AIEC strain LF82,
indicating that Gp96 promotes AIEC LF82 invasion. Gp96 has
Figure 4 Gp96-dependent invasion
involves adherent-invasive Escherichia
coli (AIEC) outer membrane protein A
(OmpA). Analysis of the interaction
between OmpA and Gp96 by pull-down
assay and ligand overlay. (A) For pull-
down, total cell extracts from Caco-2
cells were incubated with Omp
extracted from AIEC LF82 (1), LF82-
DompA (2) and E. coli K-12 MG1655 (3),
and immunoprecipitated with anti-Gp96
and Sepharose beads. In the control
assay, the incubation step with anti-
Gp96 was omitted. Captured proteins
were separated on a 12%
polyacrylamide gel, transferred onto
a nitrocellulose membrane and probed
with serum raised against OmpA. (B)
For overlay, total extracts of Caco-2
cells were separated on a 12%
polyacrylamide gel, transferred onto
a nitrocellulose membrane and probed
successively with Omp extracted from
AIEC LF82 (1), LF82-DompA (2) and E.
coli K-12 MG1655 (3), with anti-OmpA
and detected with peroxidase-
conjugated secondary antibody. (C)
Invasion abilities with Intestine-407
epithelial cells of the LF82-DompA
mutant, the LF82-DompA mutant
transformed with the cloned LF82 ompA
gene or the cloned K-12 MG1655 ompA
gene, or the pBAD33 vector alone.
Invasive bacteria were quantified as
described in figure 3A. **p<0.01
compared with the wild-type strain.
Expression of type 1 pili was determined
visually by yeast aggregation and the
titre was recorded as the last dilution
giving a positive aggregation results.
Whole-cell lysates of LF82, LF82-
DompA bacteria transformed with the
cloned LF82 ompA gene, with the cloned
K-12 ompA gene, or with the pBAD33
vector alone and grown in medium with
L-arabinose, were separated by sodium
dodecylsulfateepolyacrylamide gel
electrophoresis (SDSePAGE) and
stained with Coomassie blue. The positions of OmpC/F and OmpA are marked. (D) Effect of pretreatment of Intestine-407 epithelial cells with outer
membrane vesicles (OMVs) and anti-Gp96 antibodies (Gp96 Ab) on the invasive level of LF82-DompA. Intestine-407 cells were pretreated with rabbit
polyclonal antibodies raised against Gp96 diluted 1:500 for 30 min, then pretreated with OMVs from wild-type (WT) or LF82-DompA bacteria for 1 h
and, after washing, cells were infected with bacteria. Invasive bacteria were quantified as described in figure 3A. (E) Analysis of the interaction of LF82
or DompA OMVs with the cytoplasmic membrane of Intestine-407 epithelial cells. The fusion of OMVs with the membrane Intestine-407 cells was
analysed by confocal microscopy. Cells were incubated with OMVs at 378C for 10 min. After washing and fixation, cells were labelled with rat
antibodies raised against Gp96 and Cy3-conjugated goat anti-rat IgG secondary antibodies. OMVs fused with the cytoplasmic membrane of Intestine-
407 cells were labelled with rabbit antibodies raised against E coli lipopolysaccharide O83 and fluorescein isothiocyanate (FITC)-conjugated donkey
anti-rabbit immunoglobulin G (IgG). Each confocal microscopy image is representative of three independent experiments.
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already been reported to be a key mediator of the innate immune
response due to its ability to bind pathogenic bacteria or their
products.19e21 37 38 Indeed, Gp96 is a plasma membrane receptor
for Vip, a Listeria monocytogenes virulence factor that is required
for cell invasion and downstream signalling events.21 In addition,
a Gp96 homologue, Ecgp96, the expression of which is increased
during meningitis-associated E coli K1 infection of human
BMECs, promotes invasion of these pathogenic bacteria.19 20 37
AIEC are able to adhere to and to invade IECs; a process which
involves several virulence factors. Among them, the type 1 pili
are essential, through the recognition of CEACAM6,12 to
promote the adhesion of bacteria; however, they are not sufﬁ-
cient to promote invasion, since their expression in a non-
pathogenic E coli K-12 does not confer invasive ability.28 We have
previously reported that OMVs contribute to the invasion
process of E coli LF82 with IECs.13 OMVs are a compartment
where some virulence factors undergo full maturation, such as
the E coli pore-forming cytotoxin ClyA,39 and a potential vehicle
for intercellular transport of toxins, as shown for the Helicobacter
pylori VacA toxin,40 the E coli heat-labile toxin41 or the Actino-
bacillus actinomycetemcomitans leukotoxin.42 We have previously
reported that pretreatment of IECs with E coli LF82 OMVs
partially restores the invasion level of a non-invasive mutant and
that the effect of LF82 OMVs was speciﬁc, since no increase in
the invasion level was observed when cells were pretreated with
OMVs from non-pathogenic E coli K-12.13 The ability of native
bacterial OMVs to fuse with host cells and deliver their contents
directly into the cytosol has been theorised based on their ability
to fuse with bacterial membranes. This has been illustrated for
neisserial OMVs binding to the CEACAM1 receptor expressed
on the surface of T lymphocytes,43 and for OMVs from Pseu-
domonas aeruginosa fusing with respiratory epithelial cells.44 In
the present study, we report that AIEC strain LF82 OMVs can
fuse with IECs. In addition, we identiﬁed Gp96 as the host
membrane OMV receptor and observed that it was recruited at
the OMV fusion sites.
The outer membrane protein, OmpA, is a major protein of
OMVs and we observed that in AIEC strain LF82, deletion of the
ompA gene induced (1) a signiﬁcant decrease in the ability of the
bacteria to invade Intestine-407 epithelial cells compared with
a wild-type strain; (2) a loss of fusion of OMVs with the host
cell membrane; and (3) a loss of the ability of OMVs to restore
invasion of a non-invasive mutant. Alignment of amino acid
sequences of OmpA from AIEC LF82 and non-pathogenic E coli
K-12 MG1655 revealed ﬁve modiﬁcations in OmpA, and two
amino acid substitutions, speciﬁc to AIEC LF82, are located in
the third extracellular loop. The invasion levels of the trans-
formed LF82-DompA mutant expressing LF82 OmpA after
transcomplementation with a cloned copy of the LF82 ompA
gene were restored. In contrast, when this mutant was trans-
formed to express K-12 OmpA, it was still impaired in its
invasive ability. Furthermore, the invasion level of the LF82-
DompA mutant was restored to that of the wild-type strain
when the IECs were pretreated with LF82 OMVs, but not with
LF82-DompA OMVs. In addition, in the presence of anti-Gp96
antibodies, LF82 OMVs were unable to restore the invasive
defect of the LF82-DompA mutant, suggesting the need for an
interaction between the eukaryotic Gp96 receptor and the
bacterial OmpA protein from AIEC OMVs for fusion of vesicles
with IECs and delivery into host cells of virulence factors that
contribute to the invasion process.
Co-localisation of Gp96 and CEACAM6 was observed in
patients with CD. Gp96 participates in the folding and assembly
of many secretory and membrane proteins and has been shown
to be essential for the cell surface expression of Toll-like receptors
(TLRs), including TLR2 and TLR4.45 Therefore, we can consider
whether it participates in the cell membrane targeting of
CEACAM6. Such a co-localisation of Gp96 and CEACAM6 in
patients with CD at the apical side of ileal epithelial cells is of
great interest, since we previously reported that CEACAM6 acts
as a receptor for E coli type 1 pili and therefore allows AIEC to
colonise the ileal mucosa12 and promote gut inﬂammation as
shown in transgenic CEABAC10 mice expressing the human
CEACAM6 molecule.46 Increased expression of Gp96 at the
same site as CEACAM6 should increase AIEC virulence, since
the bacteria would be able to colonise the mucosa by binding to
CEACAM6 and can better invade the ileal epithelium through
AIEC OMVeGp96 interaction. In addition, we can speculate
that increased expression of Gp96 in patients with CD could
also contribute to an abnormal colonisation of the mucosa by
other bacteria using Gp96 as a plasma membrane receptor
allowing the bacteria to bind to or to enter inside host cells, as
already reported for L monocytogenes.21
In conclusion, our ﬁndings highlight increased expression of
the ER-localised stress response protein Gp96 in ileal epithelial
cells of patients with CD. From this result and as demonstrated
in the present study, the AIEC mostly associated with the ileal
form of CD are able to take advantage of Gp96 overexpression,
since we show here that Gp96 acts as a host cell receptor for
AIEC invasion via OMVs rich in OmpA protein. We hypothesise
that patients at high risk for developing severe ileal CD are those
who, in addition to expressing CEACAM6,12 overexpress Gp96
in the ileal mucosa. Therefore, in light of our ﬁndings, strategies
to inhibit the OmpAeGp96 interaction would be helpful to
develop new treatment options for preventing inﬂammation
resulting from gut mucosa invasion by AIEC but also by virulent
bacteria using Gp96 as a host cell receptor.
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